glp-1 eye problems Focus on drugs & 💉 Optometrists are warning GLP-1

Tirzepatide is a dual GIP and GLP-1 receptor agonist manufactured by Eli Lilly, available under two brand names: Zepbound (FDA-approved for chronic weight

The results prompt safety concerns for GLP-1RAs, especially with high dose administration, regarding gastrointestinal adverse events

The proportion of patients who had ongoing treatment, regardless of previous discontinuation episodes, ranged between approximately 70% and 80% for both drugs during a 15 year period after treatment initiation across analyses using various grace periods

RCTs using dedicated retinal imaging are required to determine the causal relationship with these therapies

Iron bisglycinate chelate (18mg, 100% DV) chelated for absorption, gentle on the stomach